ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 84 filers reported holding ORIC PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 2.93 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $207,158 | -41.8% | 34,241 | -25.4% | 0.05% | -65.2% |
Q2 2023 | $356,168 | -5.0% | 45,898 | -30.2% | 0.14% | -33.8% |
Q1 2023 | $374,940 | -48.6% | 65,779 | -46.9% | 0.20% | -44.0% |
Q4 2022 | $729,306 | +74.5% | 123,821 | -5.1% | 0.36% | +147.6% |
Q3 2022 | $418,000 | +18.4% | 130,541 | +65.8% | 0.15% | -4.5% |
Q2 2022 | $353,000 | – | 78,722 | – | 0.15% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 4,768,181 | $161,403,000 | 14.64% |
Invus Financial Advisors, LLC | 1,007,575 | $34,106,000 | 14.26% |
Euclidean Capital LLC | 1,400,435 | $47,405,000 | 10.04% |
Memorial Sloan Kettering Cancer Center | 602,272 | $20,387,000 | 8.63% |
EcoR1 Capital, LLC | 3,092,218 | $104,672,000 | 5.63% |
Ally Bridge Group (NY) LLC | 413,061 | $13,982,000 | 2.40% |
Asymmetry Capital Management, L.P. | 67,210 | $2,275,000 | 1.04% |
Orbimed Advisors | 2,921,967 | $98,909,000 | 0.86% |
Casdin Capital, LLC | 601,515 | $20,361,000 | 0.60% |
EMERALD ADVISERS, LLC | 522,302 | $17,680,000 | 0.59% |